544 research outputs found

    Preparation and Characterization of Ti(2)O(3) Films Deposited on Sapphire Substrate by Activated Reactive Evaporation Method

    Get PDF
    (001)-oriented Ti(2)O(3) films were epitaxially grown on a(001)-face of sapphire single-crystalline substrate by an activated reactive evaporation method. The formation ranges of stoichiometric and nonstoichiometric Ti(2)O(3) films were determined as a function of the substrate temperature (Ts), the oxygen pressure (Po(2)) and the deposition rate. Stoichiometric Ti(2)O(3) films were grown at Ts≧673K under Po(2)≧1.0×10(-4)Torr, which showed the metal-insulator transition with a sharp change in electrical resistivity from 3.5×10(-2) to 2.6×10(-3)Ωcm at 361K. Nonstoichiometric films prepared under less oxidized conditions did not exhibit the transition. The nonstoichiometry of the Ti(2)O(3)films was discussed in terms of excess Ti ions

    PVP2009-77360 PROPOSAL OF RATIONAL DETERMINATION OF FRACTURE TOUGHNESS LOWER-BOUND CURVES BY MASTER CURVE APPROACH

    Get PDF
    ABSTRACT The Master Curve gives the relation between the median of fracture toughness and temperature in ductile-brittle transition temperature region. The procedure to determine the Master Curve is provided in the current ASTM E1921 standard. Considering the substitution of the alternative lower-bound curves based on the Master Curve approach for the recursive KIc curves in the present codes, the statistical characteristic should be well incorporated into the determination of the lower-bound curves. The appendix in the ASTM standard provides the procedure to derive the lower-bound curves, however, it seems to be addressed without sufficient consideration on statistical reliability. In this study, we proposed a rational determination method of fracture toughness lower-bound curves based on the Master Curve approach. The method took account of the effect of sample size in the determination of the tolerance bound curve. The adequacy of the proposed method was then verified by comparing with a fracture toughness database for RPV steels. The method allows the application of the Master Curve using fewer specimens, which can coexist with the present surveillance program. INTRODUCTION The Master Curve gives the relation between the median of fracture toughness and temperature in ductile-brittle transition temperature region. The Master Curve method rests on several assumptions. One of the key assumptions of the Master Curve is that the scatter in fracture toughness is captured by the weakest link statistics with a three-parameter Weibull distribution with a slope of 4. The statistical mode

    Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model

    Get PDF
    Dabigatran and rivaroxaban are novel oral anticoagulants that specifically inhibit thrombin and factor Xa, respectively. The aim of this study is to elucidate antithrombotic properties of these anticoagulant agents under arterial and venous shear conditions. Whole blood samples treated with dabigatran or rivaroxaban at 250, 500, and 1000 nM, with/without aspirin and AR-C66096, a P2Y12 antagonist, were perfused over a microchip coated with collagen and tissue thromboplastin at shear rates of 240 and 600 s−1. Fibrin-rich platelet thrombus formation was quantified by monitoring flow pressure changes. Dabigatran at higher concentrations (500 and 1000 nM) potently inhibited thrombus formation at both shear rates, whereas 1000 nM of rivaroxaban delayed, but did not completely inhibit, thrombus formation. Dual antiplatelet agents weakly suppressed thrombus formation at both shear rates, but intensified the anticoagulant effects of dabigatran and rivaroxaban. The anticoagulant effects of dabigatran and rivaroxaban were also evaluated under static conditions using thrombin generation (TG) assay. In platelet-poor plasma, dabigatran at 250 and 500 nM efficiently prolonged the lag time (LT) and moderately reduce peak height (PH) of TG, whereas rivaroxaban at 250 nM efficiently prolonged LT and reduced PH of TG. In platelet-rich plasma, however, both anticoagulants efficiently delayed LT and reduced PH of TG. Our results suggest that dabigatran and rivaroxaban may exert distinct antithrombotic effects under flow conditions, particularly in combination with dual antiplatelet therapy
    corecore